Dr. Silvia Stingele
Angestellt, Associate Director Regulatory Affairs, MorphoSys AG
Munich, Deutschland
Werdegang
Berufserfahrung von Silvia Stingele
1 Jahr und 6 Monate, Sep. 2015 - Feb. 2017
Senior Regulatory Affairs Executive
Regulis Consulting Ltd.
8 Monate, Jan. 2015 - Aug. 2015
Regulatory Affairs Executive
Regulis Consulting Ltd.
8 Monate, Mai 2014 - Dez. 2014
Regulatory Affairs Associate
Medpace Germany GmbH
Working independently on projects as well as supporting the Regulatory Affairs Managers and Director, communication with authorities and clients, working with well-known pharmaceutical companies, gap analysis of IMPDs, specialist for the software eCTDmanager, support sponsors with orphan drug designation application and scientific advice, post marketing authorisation, product tracking after authorisation, variations, sunset clause, submissions of substantial amendments for clinical trials
1 Jahr, Mai 2013 - Apr. 2014
Trainee Regulatory Affairs and Clinical Trial Management
Medpace Germany GmbH
For RA experience see description above. Clinical Trial Management: Working in close collaboration with the Clinical Trial Manager and CRAs, coordination of international and multi-centre clinical trials, interaction with study sites and sponsors, maintenance of trial master files, organising and attending meetings with clients, writing meeting minutes, tracking and processing of clinical trial information.
5 Jahre und 2 Monate, Feb. 2008 - März 2013
Ph.D. student
Max Planck Institute
Planning and development of the PhD project, conducting experiments successfully, presenting scientific data in various occasions, teaching Master and university students, leading student projects, analysis of large scale genome and proteome data, cell culture, fluorescent microscopy, cell cycle and proliferation studies.
1 Jahr und 5 Monate, Feb. 2006 - Juni 2007
Diploma student and research associate
St. Jude Children´s Research Hospital
Biochemistry; Phosphorylation studies; Mass spectrometry; Kinase assays; Phosphorylation status of Ulk1, a gateway kinase in autophagy
8 Monate, Sep. 2004 - Apr. 2005
Research student
University of Southampton/Cancer Research Oncology Unit/Apoptosis
Molecular Oncology; PCR based assay; Detection of insertions into the Mcl-1 promoter in CLL patients and healthy individuals
Ausbildung von Silvia Stingele
2007 - 2013
International Max Planck Research School (IMPRS)
2000 - 2007
Biology
Johannes Gutenberg University Mainz
Side study: Business studies with passed exams in: Marketing, Financial accounting, Management accounting, Business management
Sprachen
Deutsch
-
Englisch
-